Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment
Mary Beth Nierengarten is a writer, editor and journalist with over 25 years of medical communications experience. She is a regular contributor to a number of online and print publications and writes in most clinical areas, as well as on health policy and economic issues. She lives in Minneapolis and can be reached at [email protected].
Articles by Mary Beth Nierengarten
2014 ACR/ARHP Annual Meeting: Lupus Nephritis
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
2014 ACR/ARHP Annual Meeting: Psoriatic Arthritis
Clinical manifestations, approaches to diagnosis, treatment
2014 ACR/ARHP Annual Meeting: Lung Fibrosis
New drugs, targeted treatments for idiopathic pulmonary fibrosis
2014 ACR/ARHP Annual Meeting: Telomeres and the Aging Immune System
How research into telomere shortening is uncovering links to immune response, inflammatory conditions
2014 ACR/ARHP Annual Meeting: Predicting Outcomes for Patients with Lupus Nephritis
Better understanding of kidney inflammation and fibrosis in LN, along with finding novel disease biomarkers could help rheumatologists gauge patients’ response to therapy
How to Launch a Rheumatology Fellowship Program
Tips on getting started, overcoming challenges, maintaining a successful fellowship program
Pediatric Chronic Pain Eased by Early Intervention, Parental Involvement
Comfort Ability program provides psychological strategies to help children self-manage symptoms
Mortality Rates Improve for Patients with Rheumatoid Arthritis
Emerging research suggests patients with RA are living longer, bolsters support for early aggressive treatment of RA
Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis
Rheumatologists urged to monitor signs of kidney dysfunction in patients with RA as higher incidence of reduced kidney function found in these patients